Navigation Links
Making bacteria make useful proteins
Date:9/6/2009

By adapting a single protein on the surface of the bacterium Caulobacter crescentus, researchers at the University of British Columbia have turned it into a protein production factory, making useful proteins that can act as vaccines and drugs. Dr. John Smit presented the findings at the Society for General Microbiology's meeting at Heriot-Watt University, Edinburgh, today (7 September).

C. crescentus is a harmless bacterium that has a single protein layer on its surface. Dr Smit's team adapted the system that secretes this protein, which self-assembles into a structure called the "S-layer", to secrete instead many proteins that are useful for vaccines and other therapeutic purposes. Or, by keeping the S-layer protein intact and genetically inserting new things inside it, they produce a very dense display of useful proteins on the cell surface and then expect to use the entire bacterium in a therapeutic application.

Bacteria are commonly used in biotechnology to produce useful protein products. If the bacteria secrete the protein rather than keep it contained within the cell, purification costs are greatly lowered. The researchers have developed a commercially available kit based on this technology, which could be especially useful in developing countries as it might be used to manufacture HIV-blocking agents very cheaply and with little specialist expertise.

"This S-layer system is very efficient at producing and secreting proteins we can make the bacterium into a protein pump, secreting over half of all the protein it makes as engineered S-layer protein," said Dr Smit, "Applications of S-layer display that we are currently developing include anti-cancer vaccines, an HIV infection blocker and agents to treat Crohn's and colitis, and diarrhoea in malnourished populations".


'/>"/>

Contact: Dianne Stilwell
diannestilwell@me.com
44-795-720-0214
Society for General Microbiology
Source:Eurekalert

Page: 1

Related biology technology :

1. Analysis of Biofuels Indirect Land Use Effects Finds the Science Lacking: Too Diffuse and Subject To Too Many Arbitrary Assumptions To Be Useful for Rule-making.
2. Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making
3. Brain research shows past experience is invaluable for complex decision making
4. Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young
5. Physicists discover important step for making light crystals
6. Patent for Making Combination Chemotherapy Work Better
7. Nanonet circuits closer to making flexible electronics reality
8. Controlling the size of nanoclusters: First step in making new catalysts
9. Making a good impression: Nanoimprint lithography tests at NIST
10. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
11. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015  Centrillion Technologies, a genomic ... from the National Human Genome Research Institute, ... (NIH). The grant will help fund the ... of breakthrough genomic technologies, including phased sequencing ... Centrillion has been developing this transformative and ...
(Date:4/17/2015)... 2015 CIO Review ( http://www.cioreview.com ) ... Most Promising Pharma and Life Science Technology Solution Providers ... compliance software platform for life sciences companies. , ... panel of experts and members of CIO Review’s editorial ... Platform has been on our radar for some time ...
(Date:4/17/2015)... 2015  Guggenheim Securities, the investment banking and capital ... of William Tanner as a Managing Director ... will start work at Guggenheim in May 2015 in ... "Bill brings a wealth of biotech experience, ... and highly acclaimed healthcare team," said Matthew Johnson ...
(Date:4/17/2015)... Global Stem Cells Group has ... 2015 April 27 - 29, 2015 in Boston. This ... areas of stem cell research including applications, biology, medicine, ... medicine. , The conference will address recent developments ... research in stem cell therapies, regenerative medicine, tissue engineering, ...
Breaking Biology Technology:MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 2Global Stem Cells Group To Join GTCbio Stem Cell and Regenerative Medicine Summit in Boston, April 27-29, 2015 3
... 3 Caliper Life,Sciences, Inc. (Nasdaq: CALP ... 26th Annual Healthcare Conference will be webcast on ... Hrusovsky, President and CEO of,Caliper, will be providing ... can be accessed at, http://www.metameetings.com/webcasts/jpmorgan/healthcare08/ . An archived,presentation ...
... MEDX ) announced today that it is scheduled ... 10:30 a.m. ET on Tuesday, January,8, 2008. The event ... the,Investor Relations section of the Medarex Web site at ... be available following the event., About Medarex, ...
... Mass., Jan. 3 Mersana, a cancer therapeutics,company, ... as Chairman of,the Company,s Board of Directors. Mr. ... a significant record of accomplishment over a,30-year industry ... welcome Boyd Clarke as Chairman of our Board,of ...
Cached Biology Technology:Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors 2
(Date:4/14/2015)... April 14, 2015  HYPR Corp. today announced ... ® ) Alliance tm , an industry consortium ... commit to share technology and collaborate to deliver ... interoperable, more secure and private, and easier to ... verification that protects sensitive user information and eliminates ...
(Date:4/9/2015)... April 9, 2015 Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 2015, after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
(Date:4/2/2015)... , April 2, 2015 According ... 2015 attributed to somewhat higher than 125 MSEK. This ... year-end report 2014 that revenues for Q1 2015 would ... company reported for Q4 2014. The operating result for ... negative. The complete interim report will as previously communicated ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2
... University biologist has been awarded over $2.3 million from ... of the human pathogen chlamydia in hopes of finding ... disease in the United States. David E. Nelson, ... Arts and Sciences, Department of Biology, and researchers in ...
... invading virus hijacks a cell,s workings by imitating a ... cell signals, the virus destroys a defensive protein designed ... cell cultures, may represent a broader targeting strategy used ... for developing more effective treatments for infectious diseases. ...
... buzz of the golden-winged warbler,s song might not sound like ... population of this little, gray songbird with bright yellow patches ... since 1966. And, as of yet, it remains unprotected by ... dire situation for the warbler, and Ronald Canterbury wants people ...
Cached Biology News:In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics 2In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics 3To drive infections, a hijacking virus mimics a cell's signaling system 2UC research: Saving habitat key to songbird's survival 2
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
... polyclonal to FbxL7 The F ... which it was originally observed, is ... binds SKP1. F-box proteins are components ... called SCFs (SKP1, cullin, F-box proteins), ...
Goat polyclonal to XAGE1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGFGFRRQGEDNT, corresponding to C terminal amino acids 149-160 of Human XAGE1 Entrez Gene ID: 9...
Biology Products: